NeuroNavigATTR Sponsored Testing Program
Use
The NeuroNavigATTR Sponsored Testing Program offers no-charge genetic testing to identify hereditary ATTR amyloidosis. It's designed for US residents aged 18 and older, particularly those with a family history of hATTR, positive PYP or biopsy for amyloidosis, and other specific eligibility criteria. This helps in timely identification and management of hereditary ATTR conditions.
Special Instructions
Patients must meet specific eligibility criteria detailed in the requisition form. Testing must be ordered by a qualified healthcare professional, and samples should be collected and shipped following instructions provided in the testing kit. Genetic counseling is available at no cost through Genome Medical.
Limitations
Testing is limited to individuals who meet the specified eligibility criteria, such as US residency and appropriate clinical indicators. Specimens like saliva and buccal swabs may have contamination issues affecting quality. The test isn't FDA-approved or NY state-approved, requiring additional paperwork if collected in New York.
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
2-3 weeks
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
3 ml - 5 ml
Minimum Volume
1 ml
Container
EDTA (purple top tube) or ACD (yellow top tube)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | up to 80 days |
| Refrigerated | up to 8 days |
| Frozen | up to 1 month |